Ani Pharmaceuticals (ANIP) Research & Development (2016 - 2025)
Historic Research & Development for Ani Pharmaceuticals (ANIP) over the last 17 years, with Q3 2025 value amounting to $12.3 million.
- Ani Pharmaceuticals' Research & Development rose 2148.5% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.0 million, marking a year-over-year increase of 4826.99%. This contributed to the annual value of $44.6 million for FY2024, which is 3002.68% up from last year.
- According to the latest figures from Q3 2025, Ani Pharmaceuticals' Research & Development is $12.3 million, which was up 2148.5% from $16.5 million recorded in Q2 2025.
- Over the past 5 years, Ani Pharmaceuticals' Research & Development peaked at $16.6 million during Q4 2024, and registered a low of $2.5 million during Q3 2021.
- In the last 5 years, Ani Pharmaceuticals' Research & Development had a median value of $7.4 million in 2023 and averaged $8.0 million.
- Its Research & Development has fluctuated over the past 5 years, first crashed by 5321.56% in 2021, then surged by 21176.71% in 2022.
- Quarter analysis of 5 years shows Ani Pharmaceuticals' Research & Development stood at $3.1 million in 2021, then skyrocketed by 66.31% to $5.2 million in 2022, then surged by 88.95% to $9.9 million in 2023, then surged by 68.7% to $16.6 million in 2024, then dropped by 26.08% to $12.3 million in 2025.
- Its Research & Development was $12.3 million in Q3 2025, compared to $16.5 million in Q2 2025 and $10.6 million in Q1 2025.